Ligand Pharmaceuticals | LGND - Ordinary Share Capital

Stock Price
213.21
Daily Change
-5.77 -2.63%
Monthly
-4.49%
Yearly
103.95%
Q2 Forecast
208.92

Ligand Pharmaceuticals reported $19.66M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Agenus USD 35.32M 2.51M Dec/2025
Amgen USD 540M 1000K Mar/2026
Anika Therapeutics USD 13.89M 532K Dec/2025
Arrowhead Research USD 137.39M 1.69M Dec/2025
Baxter International USD 516.45M 2.17M Mar/2026
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Eli Lilly USD 943.5M 3.33M Mar/2026
Enanta Pharmaceuticals USD 212K 1000 Dec/2023
Enviri Corporation USD 81.45M 797K Dec/2025
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Glaxosmithkline GBP 4.08B 49.43M Dec/2025
Heron Therapeutics USD 188.31M 4.99M Dec/2025
Insmed USD 216.52M 2.27M Mar/2026
Intrexon USD 0 0 Jun/2024
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025
Ligand Pharmaceuticals USD 19.66M 19.64M Sep/2025
MacroGenics USD 63.32M 60K Dec/2025
Merck USD 2.47B 12.72M Dec/2025
Pacira USD 39.31M 1.81M Mar/2026
Pfizer USD 5.7B 13M Mar/2026
Rigel Pharmaceuticals USD 17K 158K Jun/2024
Veracyte USD 79.79M 743K Mar/2026